The age at diagnosis of MDS/AML patients with germline DDX41 mutations has been reported within a wide range from 57 to 70 years, but most studies reported that it is comparable to patients with general MDS/AML [34,35,36,50,58]. This evidence concerns the gene DDX41 and myelodysplastic syndrome.